Scientific article
English

The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents

Published in

International journal of cardiology, vol. 168, no. 2, p. 1466-1471

Publication date

2013

Abstract

We aimed to assess the cost effectiveness of the sirolimus-eluting stent (SES) in diabetic and non-diabetic patients vs. bare metal stents (BMS).

Keywords

  • Aged
  • Cohort Studies
  • Cost-Benefit Analysis/methods/trends
  • Drug-Eluting Stents/economics/trends
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Metals/economics
  • Middle Aged
  • Myocardial Revascularization/economics/trends
  • Registries
  • Risk Factors
  • Stents/economics/trends

UNIGE research groups

Citation (ISO format)

BARONE-ROCHETTE, Gilles et al. The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents. In: International journal of cardiology, 2013, vol. 168, n° 2, p. 1466–1471. doi: 10.1016/j.ijcard.2012.12.054

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0167-5273
588views
0downloads

Technical informations

Creation

24/11/2014 15:05:00

First validation

24/11/2014 15:05:00

Update

14/03/2023 22:20:49

Status update

14/03/2023 22:20:48

Last indexation

30/10/2024 21:02:28
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated